Studies have shown that lower-than-normal blood adiponectin concentrations are associated with several metabolic disorders, including obesity, type 2 diabetes mellitus, cardiovascular disease, and metabolic syndrome [15]. Here, ADIPOQ is linked to metabolic syndrome.